The Decline of Deep Brain Stimulation for Obsessive–Compulsive Disorder Following FDA Humanitarian Device Exemption Approval
Background: In February 2009, the US Food and Drug Administration (FDA) granted Humanitarian Device Exemption (HDE) for deep brain stimulation (DBS) in the anterior limb of the internal capsule (ALIC) for the treatment of severely debilitating, treatment refractory obsessive–compulsive disorder (OCD...
Main Authors: | Heather Pinckard-Dover, Herbert Ward, Kelly D. Foote |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Surgery |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fsurg.2021.642503/full |
Similar Items
-
Habenular Stimulation for Neurosurgery Resistant Obsessive-Compulsive Disorder: A Case Report
by: Chencheng Zhang, et al.
Published: (2020-02-01) -
Psychometric Assessment of the Yale–Brown Obsessive-Compulsive Scale—Second Edition
by: Samira Masumian, et al.
Published: (2019-02-01) -
Executive Functioning in Chinese Patients With Obsessive Compulsive Disorder
by: Huicong Ren, et al.
Published: (2021-08-01) -
Prevalence of obsessive-compulsive spectrum disorders in obsessive-compulsive disorder
by: Mohammad Aleem Siddiqui, et al.
Published: (2018-01-01) -
Exploratory Study of Obsessive Compulsive Symptoms in Schizophrenia
by: E Sivabalan, et al.
Published: (2017-01-01)